埃塞俄比亚的亚托邦性皮肤炎及其相关因素:系统审查和元分析
Tadele Lankrew Ayalew1, Mulualem Gete Feleke2, Kidist Ashager2
1Department of Nursing, School of Nursing, College of Health Science and Medicine, Wolaita Sodo University, P.O. Box 138, Sodo, Ethiopia. tadelelankrew@gmail.com.
BMC infectious diseases
|November 26, 2025
概括
亚托邦性皮肤炎影响了26%的埃塞俄比亚人,区域差异很大. 关键的风险因素包括虫感染,家族过敏史和环境暴露,需要有针对性的公共卫生战略.
科学领域:
- 皮肤病学和公共卫生
背景情况:
- 亚托皮炎是一种普遍的,慢性炎症性皮肤疾病,影响全球生活质量.
- 埃塞俄比亚有关亚托皮性皮肤炎患病率和风险因素的有限数据阻碍了有效的管理.
研究的目的:
- 确定埃塞俄比亚的亚托皮性皮肤炎的流行率和相关因素.
- 进行系统性审查和元分析,以获得可靠的流行病学见解.
主要方法:
- 对埃塞俄比亚阿托皮性皮肤炎的观察性研究进行系统审查和元分析.
- 在多个数据库 (PubMed,Embase,Scopus等) 进行了搜索. 在2025年8月之前.
- 采用随机效应建模用于聚合流行率和赔率比率,并进行异质性和偏差评估.
主要成果:
- 在埃塞俄比亚,阿托皮性皮肤炎的综合流行率为26% (95% CI: 16.70-35.29%).
- 观察到显著的区域差异,埃塞俄比亚中部患病率最高 (76.92%) 和蒂格莱 (9.54%) 患病率最低.
- 确定的危险因素:虫感染 (AOR=2.80),家庭过敏史 (AOR=3.74),个人过敏史 (AOR=3.52),以及环境过敏原暴露 (AOR=3.75).
结论:
- 在埃塞俄比亚,亚托邦性皮肤炎非常普遍,区域差异很大.
- 虫感染,过敏史和环境暴露是重要的风险因素.
- 强调埃塞俄比亚需要有针对性的干预措施和全面的公共卫生战略.
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K


